Literature DB >> 1868981

Soluble cytokine receptors: their role in immunoregulation.

R Fernandez-Botran1.   

Abstract

A number of cytokine receptors exist in soluble form in the biological fluids of both animals and humans, a phenomenon that might have immunoregulatory implications in vivo. Although these soluble receptors specifically inhibit binding and activity of their respective cytokines in vitro, their actual function in vivo as cytokine inhibitors or as carrier proteins is unclear. Abnormalities in the production of these substances might contribute to the pathophysiology of immune and neoplastic diseases. Besides their role in regulating cytokine activity in vivo, soluble cytokine receptors hold significant potential for therapeutic use as very specific anticytokine agents and as indicators in diagnosis and assessment of immune parameters, prognosis, disease progression, response to treatment, etc., in a variety of autoimmune and malignant diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868981     DOI: 10.1096/fasebj.5.11.1868981

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  45 in total

1.  Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.

Authors:  S M Hsu; S S Xie; P L Hsu; J A Waldron
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus.

Authors:  M Itoh; Y Goto; Y Ohta; Y Goto; H Ohashi
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2a.

Authors:  Yu-Jin Lee; Xiaozhen Zhang; Estefania Vazquez; Gayathri Shivasabesan; Howard A Young; Alison Murphy; Honghui Wang; Anthony F Suffredini; Ulrich Siebenlist; Shyam Kottilil
Journal:  J Interferon Cytokine Res       Date:  2013-10-30       Impact factor: 2.607

Review 4.  Regulation of apoptosis in immune cells.

Authors:  J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

5.  CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.

Authors:  V Bazil; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia.

Authors:  H Redl; G Schlag; G R Adolf; B Natmessnig; J Davies
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytes.

Authors:  R Dummer; J C Meyer; B K Ballmer-Weber; S Muletta; R Panizzon; G Burg
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.

Authors:  M A Wasik; N Sioutos; M Tuttle; J R Butmarc; W D Kaplan; M E Kadin
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Bipolar Disord       Date:  2015-08-08       Impact factor: 6.744

10.  Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients.

Authors:  Hooriyah S Rizavi; Xinguo Ren; Hui Zhang; Runa Bhaumik; Ghanshyam N Pandey
Journal:  Psychiatry Res       Date:  2016-04-22       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.